Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance

  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Hydroxyurea Capsules USP 500 mg
  Indications :
 

Myeloma.

Resistant chronic myelotic leukemia.

Recurrent,Metastatic or inoperable carcinoma of the ovary.

Primary squamous cell(epidermal) carcinomas of the head and the neck cancer, excluding the lip.

Melanoma, Resistant chronic myelocytic leukemia.

   
  Dosage :
  ADULTS : Initial doses is 150 mg/m2 once daily for 5 consecutive days per 25 days treatment.

INTERMITTENT THERAPY : 80mg/kg administered orally as a single dose every third day.

CONTINUOUS THERAPY : 20 to 30 mg/kg administered orally as a single dose daily.

Dosage Adjustment :

Renal Impairment : Required.

Hepatic Impairment : Administer with caution.
   
  Packing : 10 Strips of 10 Capsules
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.